porno izle
porno
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi
sisli escort mecidiyekoy escort
replica watches
Neodyum Miknatis
implant
porno

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Diamond Pharma Services supports GenSight Biologics in submitting its first Marketing Authorisation Application, for ocular gene therapy LUMEVOQ

Diamond Pharma Services (“Diamond”), a leading technical services and regulatory affairs consulting group, has announced that it provided EU regulatory, pharmacovigilance, quality and compliance support to GenSight Biologics (“GenSight”), including the preparation, authoring support, agency communication and submission of GenSight’s first Marketing Authorisation Application to the European Medicines Agency (EMA), for its novel ocular gene therapy LUMEVOQ®.  The EMA decision is expected in H2 2021.

Read the rest of entry »

RSSL Launches Sterility Webinar Series

Hosted by Tim Sandle, RSSL’s complimentary sterility webinar series continues with three new sessions to guide you through the complexities around COVID-19 prevention measures, best practices for cleaning and sterility testing.

Read the rest of entry »

Yourgene Health: IONA® Nx awarded contract with St George’s NHS Hospital 

Yourgene, the international molecular diagnostics group, announces that it has been awarded the contract for non-invasive prenatal testing (NIPT) using its newly-launched IONA® Nx NIPT Workflow ('IONA® Nx'),

Read the rest of entry »

The BioSphere: Ground-breaking cancer diagnostics spin out that looks to save up to 2,000 lives each year joins Newcastle Helix eco-system

The Biosphere, a specialist lab facility on Newcastle Helix, has welcomed yet another Newcastle University spin-out, who has developed and commercialised a prognostic test for early-stage skin cance

Read the rest of entry »

Enesi Pharma: ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Best New Vaccine Technology/Platform Award at the World Vaccine Congress

Enesi Pharma is delighted to announce that ImplaVax® has won the ‘Best New Vaccine Technology/Platform Award’ at the World Vaccine Congress Washington Virtual annual event (28 September – 1 October 2020).

Read the rest of entry »

AMSBIO: Announce StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells (MSC)**.

AMSBIO announce StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells (MSC)**. StemFit® for MSC is the latest addition to the StemFit® family of stem cell media.  It is a chemically defined and human/animal origin free medium, optimized for the isolation and culture of MSCs from bone marrow (BM-MSC), umbilical cord (UC-MSC), and adipose (ADSC) under serum-free, human platelet lysate free conditions.

 

Read the rest of entry »

Enesi Pharma: ImplaVax®-Enabled, Solid-Dose Modified Live Virus Vaccine

Enesi Pharma’s ImplaVax®-Enabled, Solid-Dose Modified Live Virus Vaccine Produces Neutralising Antibody and T-Cell Responses Equivalent to Liquid Vaccine Delivered via Needle and Syringe

Read the rest of entry »

Enesi Pharma: Appoints Vaccine Development Expert Dr Keith Howard As Chief Scientific Officer

OXFORD, UK – 28 September 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its world leading ImplaVax® technologies, is delighted to announce the appointment of Keith Howard as Chief Scientific Officer.

Read the rest of entry »

Yourgene Health: Announces the launch of Yourgene Genomic Services

Manchester, UK – 28 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of Yourgene Genomic Services, an integration and expansion of the Company’s international service laboratory offerings.  Yourgene Genomic Services becomes a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations.  

Read the rest of entry »

RSSL launches bespoke nitrosamine test service

Reading Scientific Services Ltd (RSSL) has expanded its pharmaceutical assessment capabilities with the introduction of a robust analytical method designed to determine the presence of nitrosamines. Using highly-sensitive mass spectrometers in conjunction with a range of separation techniques, the new service can not only reach exceptionally low regulatory thresholds, but also accommodate a wide variety of pharmaceutical products and active species.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.